Shiva Zaman

Department ofInternal Medicine, Emory University Hospital, Georgia, United States

Publications
  • Case Report   
    A Case Report: Antibody Response to 2-Dose Pfizer Vaccine and Johnson & A Case Report: Antibody Response to 2-Dose Pfizer Vaccine and Johnson &
    Author(s): Gita Taasoobshirazi*, Shiva Zaman and Katayun Taasoobshirazi

    Recent research has shown that immunocompromised individuals are less likely to build detectible SARS-CoV-2 spike protein antibodies after vaccination. This is distressing for the 11.5 million individuals on some form of immunosuppressive therapy as the SARS-CoV-2 virus can lead to more severe illness and greater risk for death among these individuals. This study fills a gap in the research on COVID-19 vaccination in immunocompromised individuals with a case study of how a kidney transplant patient responded to a series of COVID-19 vaccines. The case study presented in this paper introduces the vaccination schedule and antibody testing of a kidney transplant patient in effort to assess the efficacy of a series of SARS-CoV-2 vaccines. The patient did not make SARS-CoV-2 spike protein antibodies, as assessed by a Spike Protein IgG Antibody blood test, after a two-dose schedule of the Pf.. Read More»

    Abstract PDF